These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10961669)

  • 1. CuZn-superoxide dismutase transgenic mice: no effect on longevity, locomotor activity and 3H-mazindol and 3H-spiperone binding over 19 months.
    Gallagher IM; Jenner P; Glover V; Clow A
    Neurosci Lett; 2000 Aug; 289(3):221-3. PubMed ID: 10961669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative autoradiographic distribution of [3H]mazindol-labeled dopamine uptake sites in the brains of superoxide dismutase transgenic mice.
    Cadet JL; Przedborski S; Kostic V; Jackson-Lewis V; Carlson E; Epstein CJ
    Brain Res Bull; 1990 Jul; 25(1):187-92. PubMed ID: 2119856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma-aminobutyric acidA and benzodiazepine receptor alterations in the rat brain after unilateral 6-hydroxydopamine lesions of the medial forebrain bundle.
    Araki T; Matsubara M; Fujihara K; Kato H; Imai Y; Itoyama Y
    Neurol Res; 2002 Jan; 24(1):107-12. PubMed ID: 11783749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of pergolide and (-)-deprenyl on 3H-mazindol and 3H-spiperone binding in rat brain.
    Gallagher IM; Clow A; Jenner P; Glover V
    Neurobiol Aging; 1999; 20(6):709-13. PubMed ID: 10674438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitous overexpression of CuZn superoxide dismutase does not extend life span in mice.
    Huang TT; Carlson EJ; Gillespie AM; Shi Y; Epstein CJ
    J Gerontol A Biol Sci Med Sci; 2000 Jan; 55(1):B5-9. PubMed ID: 10719757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-Hydroxydopamine-lesioning of the nigrostriatal pathway in rats alters basal ganglia mRNA for copper, zinc- and manganese-superoxide dismutase, but not glutathione peroxidase.
    Kunikowska G; Jenner P
    Brain Res; 2001 Dec; 922(1):51-64. PubMed ID: 11730701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress and dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease.
    Visser JE; Smith DW; Moy SS; Breese GR; Friedmann T; Rothstein JD; Jinnah HA
    Brain Res Dev Brain Res; 2002 Feb; 133(2):127-39. PubMed ID: 11882343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
    Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpected differences between mazindol and its homologs on biochemical and behavioral responses.
    Heikkila RE; Cabbat FS; Manzino L; Babington RG; Houlihan WJ
    J Pharmacol Exp Ther; 1981 Jun; 217(3):745-9. PubMed ID: 7194909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin restores glutathione peroxidase activity in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced neurotoxicity in C57BL mice and stimulates murine astroglial glutathione peroxidase production in vitro.
    Genc S; Akhisaroglu M; Kuralay F; Genc K
    Neurosci Lett; 2002 Mar; 321(1-2):73-6. PubMed ID: 11872260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice deficient in CuZn-superoxide dismutase or glutathione peroxidase.
    Zhang J; Graham DG; Montine TJ; Ho YS
    J Neuropathol Exp Neurol; 2000 Jan; 59(1):53-61. PubMed ID: 10744035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transgenic mice overexpressing copper-zinc superoxide dismutase: a model for the study of radical mechanisms and aging].
    Ceballos-Picot I
    C R Seances Soc Biol Fil; 1993; 187(3):308-23. PubMed ID: 8019910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of mazindol on brain dopamine turnover in spiperone-treated rats.
    Fuller RW; Snoddy HD
    J Neural Transm; 1979; 44(1-2):13-9. PubMed ID: 438800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Food-intake and locomotor activity: effects of mazindol and spiperone [proceedings].
    Cooper SJ; Sweeney KF
    Br J Pharmacol; 1978 Jun; 63(2):412P-413P. PubMed ID: 667485
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological studies with several analogs of mazindol: correlation between effects on dopamine uptake and various in vivo responses.
    Heikkila RE; Babington RG; Houlihan WJ
    Eur J Pharmacol; 1981 May; 71(2-3):277-86. PubMed ID: 7250190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to striatal dopamine depletion induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice expressing human mutant Cu,Zn superoxide dismutase.
    Fornai F; Carrì MT; Ferri A; Paolucci E; Prisco S; Bernardi G; Rotilio G; Mercuri NB
    Neurosci Lett; 2002 Jun; 325(2):124-8. PubMed ID: 12044637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down syndrome clinical symptoms are manifested in transfected cells and transgenic mice overexpressing the human Cu/Zn-superoxide dismutase gene.
    Groner Y; Elroy-Stein O; Avraham KB; Yarom R; Schickler M; Knobler H; Rotman G
    J Physiol (Paris); 1990; 84(1):53-77. PubMed ID: 1972759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superoxide dismutase, catalase, and glutathione peroxidase activities in copper/zinc-superoxide dismutase transgenic mice.
    Przedborski S; Jackson-Lewis V; Kostic V; Carlson E; Epstein CJ; Cadet JL
    J Neurochem; 1992 May; 58(5):1760-7. PubMed ID: 1560230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson's disease?
    Thiruchelvam M; Brockel BJ; Richfield EK; Baggs RB; Cory-Slechta DA
    Brain Res; 2000 Aug; 873(2):225-34. PubMed ID: 10930548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological modifications of dopamine transmission do not influence the striatal in vivo binding of [3H]mazindol or [3H]cocaine in mice.
    Thibaut F; Bonnet JJ; Vaugeois JM; Costentin J
    Neurosci Lett; 1996 Mar; 205(3):145-8. PubMed ID: 8852579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.